In conclusion, our results suggest that central obesity and MetS are associated with an impairment of phospholipid remodelling and HDL composition, partially led by reduced LCAT activity and correlating with obesity and insulin resistance. The gene discussed is LCAT; the disease is metabolic syndrome.